Gravesʼ Orbitopathy: Current Concepts for Medical Treatment

M Oeverhaus, M Stöhr, L Möller… - Klinische …, 2021 - thieme-connect.com
Hintergrund Die Therapie schwerer Manifestationsformen der endokrinen Orbitopathie (EO)
ist immer noch eine Herausforderung und verlangt eine gute interdisziplinäre …

[HTML][HTML] Predicting the course of Graves' orbitopathy using serially measured TSH-receptor autoantibodies by automated binding immunoassays and the functional …

M Stöhr, M Oeverhaus, SD Lytton… - Hormone and …, 2021 - thieme-connect.com
The aim of the study was to investigate the use of serial measurements of TSH-receptor
autoantibodies (TRAb) with the newest available assay technology to predict the course of …

Radioiodine ablation of thyroid remnants in patients with Graves' orbitopathy

…, J Koenen, N Bechrakis, M Stöhr… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Our purpose was to assess response after ablation of thyroid remnants (ATR) with
radioactive iodine therapy in patients with unstable Graves’ orbitopathy (GO) after subtotal …

[HTML][HTML] Predicting the relapse of hyperthyroidism in treated Graves' disease with orbitopathy by serial measurements of TSH-receptor autoantibodies

M Stöhr, M Oeverhaus, SD Lytton… - Hormone and …, 2021 - thieme-connect.com
The aim of this study was to investigate the potential of the new TSH-receptor antibody (TRAb)
assays to predict remission or relapse of hyperthyroidism in patients with Graves’ disease …

[HTML][HTML] Evaluation of a retinal projection laser eyewear in subjects with visual impairment caused by corneal diseases in a randomized trial

M Stöhr, D Dekowski, N Bechrakis, M Oeverhaus… - Ophthalmology, 2023 - Elsevier
Purpose Patients with incurable corneal diseases experience visual impairment despite having
a healthy retina and optic pathway. Low vision aids (LVAs) are prescribed to optimize the …

First evaluation of a retinal imaging laser eyewear system based low vision aid

M Stöhr, D Dekowski, N Bechrakis, J Esser… - Clinical …, 2020 - Taylor & Francis
Purpose We conducted this trial to investigate a new wearable laser-eyewear (LEW). Images
of an integrated camera are projected to the retina by a RGB-Laser (<1µW) and MEMS-…

Update endokrine Orbitopathie

A Eckstein, M Oeverhaus, M Stöhr… - Der …, 2019 - thieme-connect.com
Graves’ orbitopathy (GO) is the most common extrathyroideal manifestation of Graves’
disease. Therapy depends on activity (active, inactive) and severity (mild, moderate-to-severe, …

Current Therapeutic Approaches for Graves' Orbitopathy-are Targeted Therapies the Future?

A Eckstein, M Stöhr, GE Görtz… - Klinische …, 2024 - pubmed.ncbi.nlm.nih.gov
Die endokrine Orbitopathie (EO) ist eine Autoimmunerkrankung der Augenhöhle, die am
allerhäufigsten im Zusammenhang mit einer Schilddrüsenautoimmunerkrankung vom Typ …

Aktuelle Therapieansätze der endokrinen Orbitopathie–sind die zielgerichteten Therapien die Zukunft?

A Eckstein, M Stöhr, GE Görtz, A Gulbins… - Klinische …, 2024 - thieme-connect.com
Gravesʼ orbitopathy is an autoimmune disease of the orbit that most frequently occurs with
Gravesʼ hyperthyroidism. The occurrence of autoantibodies directed against the TSH …

Primary and secondary superior rectus recessions to correct vertical deviations in Graves' orbitopathy patients

…, M Oeverhaus, D Dekowski, M Stöhr… - Acta …, 2021 - Wiley Online Library
Purpose Patients with vertical strabismus and consecutive diplopia due to Graves’ orbitopathy
(GO) might need recession of the rectus superior muscle. The aim of this retrospective …